Products

LesionQuant
CorTechs Labs
Neurology AI
LesionQuant, an FDA-approved AI product by CorTechs Labs, is particularly useful for patients with multiple sclerosis. It provides brain structure data and quantifies the number, size, and location of lesions, comparing them to prior studies.
OnQ Neuro
CorTechs Labs
Neurology AI
OnQ Neuro by CorTechs Labs is an FDA-cleared, AI-powered software for automated segmentation and volumetric quantification of brain tumors on MRI, supporting clinical analysis and interpretation.

See all 2 products →

About CorTechs Labs

CorTechs Labs, which rebranded to Cortechs.ai in 2020, is a healthcare AI company specializing in advanced medical imaging solutions. The company develops and markets breakthrough medical device software that quantifies and tracks neurodegenerative diseases and assists in the detection of clinically significant cancer. Their flagship product, NeuroQuant®, is a 510(k) cleared medical device that provides quantitative analysis of MRI images of the human brain, making it a routine part of clinical practice. This cloud-based AI software is designed to segment, quantify, and compare brain structure volume for neurodegenerative diseases, integrating seamlessly into radiology workflows.

For physicians, Cortechs.ai’s solutions offer objective, volumetric data and color-coded brain structure analysis to support clinical impressions, aiming to increase diagnostic accuracy and reduce variability between readers. The technology allows for the identification and assessment of neurodegeneration in its earliest stages, facilitating better treatment and lifestyle planning for patients. Their offerings extend to a range of medical conditions, including Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma, and brain development abnormalities, as well as brain and prostate tumors. The company’s commitment is to empower physicians and clinicians with AI solutions to better detect, diagnose, and treat diseases by merging state-of-the-art medical imaging with machine learning and clinical data.

Focus Areas

AI-powered medical imaging neuroimaging quantitative analysis neurological diseases oncological diseases Alzheimer's disease epilepsy multiple sclerosis brain trauma prostate cancer

Business Intelligence

TechnologyCloud-based technology, AI-driven insights, automated segmentation and volumetric analysis, machine learning, deep learning

What Physicians Need to Know

Neuroimaging & Neurodegenerative Diseases
CorTechs Labs, now Cortechs.ai, specializes in quantitative MRI analysis for neurodegenerative diseases like Alzheimer's Disease, Multiple Sclerosis, Epilepsy, and Traumatic Brain Injury. Their flagship product, NeuroQuant®, provides automated volumetric measurements of brain structures, comparing them to a normative database to aid in early detection, diagnosis, and monitoring of disease progression. They also offer NeuroQuant® MS for visualizing and tracking lesions in Multiple Sclerosis, and NeuroQuant® PET for rapid, automated subregional tracer quantification in Alzheimer's and other cognitive impairments.
Oncology
Cortechs.ai provides AI-powered solutions for oncology, specifically focusing on Brain Tumors and Prostate Cancer. NeuroQuant® Brain Tumor offers pre- and post-operative 3D volume analysis of brain tumors, including gliomas, brain metastases, and meningiomas, enabling comprehensive quantification of tumor burden and monitoring changes over time. For Prostate Cancer, their OnQ™ Prostate solution leverages advanced MRI analytics with Restriction Spectrum Imaging (RSI) to improve the detection and diagnosis of clinically significant prostate cancer.
Quantitative Imaging & AI-Powered Diagnostics
Cortechs.ai is a pioneer in quantitative medical imaging, merging state-of-the-art medical imaging with machine learning and clinical data. Their AI-powered software, including NeuroQuant®, NeuroQuant® CT, and NeuroQuant® PET, transforms medical images into objective, measurable insights, supporting faster interpretation and more confident clinical decision-making. They emphasize evidence-based validation and responsible AI deployment.
Clinical Decision Support
Cortechs.ai's solutions are designed to empower physicians with AI tools for better detecting, diagnosing, and treating diseases. Their automated analysis reduces inter-reader variability and provides objective data and visualizations to support more informed clinical decisions across neurology, oncology, and radiology practices.
Physician Tip

Cortechs.ai's tools, such as NeuroQuant®, integrate seamlessly into existing radiology workflows without requiring a user interface once installed. They are compatible with common imaging systems from vendors like GE, Siemens, Philips, Canon, and Fuji, and support various MR scanner field strengths (1.2T, 1.5T, 3.0T), as well as PET and PET/CT systems. This broad compatibility and automation reduce the need for manual data entry and minimize transcription errors. The software provides objective, quantitative data and visualizations that can be easily understood by both healthcare professionals and patients, fostering greater confidence in care.

Cortechs.ai's solutions are available through secure cloud-based or on-premise systems, allowing clinicians to upload and retrieve results from virtually anywhere with internet access. They offer seamless integration into Picture Archiving and Communication Systems (PACS) and structured reporting systems. Recent partnerships, such as with CARPL.ai, further expand global access to their AI imaging solutions through a unified AI ecosystem. They also collaborate with companies like Viz.ai to integrate their neuroimaging suite into care coordination platforms. Their technology is validated across multiple vendors and field strengths, ensuring compatibility with most existing imaging infrastructure.

Products by CorTechs Labs

2 products in the directory

LesionQuant
CorTechs Labs
Neurology AI
LesionQuant, an FDA-approved AI product by CorTechs Labs, is particularly useful for patients with multiple sclerosis. It provides brain structure data and quantifies the number, size, and location of lesions, comparing them to prior studies.
OnQ Neuro
CorTechs Labs
Neurology AI
OnQ Neuro by CorTechs Labs is an FDA-cleared, AI-powered software for automated segmentation and volumetric quantification of brain tumors on MRI, supporting clinical analysis and interpretation.

What the Web Says

CorTechs Labs generally receives positive feedback for its neuroimaging software, particularly for its accuracy and user-friendliness in quantifying brain structures for neurological conditions. Employer reviews indicate a supportive work environment with opportunities for growth, though some mention challenges with compensation or management communication.

Overall: Positive

Strengths

  • Accurate and reliable neuroimaging quantification (e.g., for Alzheimer's, MS)
  • User-friendly interface and intuitive software
  • Responsive and helpful customer support
  • Supportive and collaborative work environment
  • Meaningful work contributing to healthcare
  • Opportunities for professional growth and learning

Limitations

  • Pricing can be a barrier for smaller practices or individual researchers
  • Some users desire more advanced features or customization options
  • Occasional reports of slow software performance or bugs
  • Compensation may not always be competitive with larger tech companies
  • Communication from upper management could be improved
  • Limited work-life balance at times due to workload

Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT News (general industry sentiment)

Last updated: 2026-10-17

Videos

News, demos, and interviews about CorTechs Labs.

Loading videos...

Videos load interactively. If none appear, search YouTube for CorTechs Labs →

View all on YouTube

Press & Coverage

Cortechs.ai
Cortechs.ai and CARPL.ai Partner to Expand Global Access to AI-Powered Imaging Solutions
Cortechs.ai announced a strategic partnership with CARPL.ai to make its AI imaging solutions, including NeuroQuant and OnQ Prostate, available through CARPL.ai's platform, expanding global access to quantitative neuroimaging tools.
2026-10
Cortechs.ai
NeuroQuant® PET Receives FDA 510(k) Clearance
Cortechs.ai received FDA 510(k) clearance for NeuroQuant® PET, advancing automated PET quantification for assessing cognitive impairment.
2026-08
MedPath Trial
FDA Clears Cortechs.ai's NeuroQuant PET for Quantitative Amyloid Imaging in Cognitive Impairment
Cortechs.ai's NeuroQuant PET received FDA 510(k) clearance (K261916) for automated quantification and clinical interpretation of amyloid PET imaging.
2026-08
Cortechs.ai
Cortechs.ai Collaborates with Microsoft to Bring AI-Powered Imaging Insights Directly into Radiology Workflows
Cortechs.ai announced a collaboration with Microsoft to integrate its quantitative imaging applications, including NeuroQuant and OnQ Prostate, into Microsoft's radiology reporting solutions like PowerScribe One.
2026-06
Cortechs.ai
Cortechs.ai and Siemens Healthineers Partner to Expand Global Access to NeuroQuant® Technologies
Cortechs.ai partnered with Siemens Healthineers to integrate and distribute NeuroQuant® Lesion Surveillance through the Siemens Healthineers Digital Marketplace, aiming to accelerate global adoption of quantitative brain imaging.
2026-03
Cortechs.ai
Cortechs.ai Expands Partnership with Strategic Radiology to Advance Imaging Innovation
Cortechs.ai announced an expanded partnership with Strategic Radiology, a coalition of independent radiology practices, to advance imaging innovation.
2025-10
Cortechs.ai
Cortechs.ai and deepc Announce Strategic Partnership to Advance AI Integration in Radiology
Cortechs.ai announced a collaboration with deepc, a platform provider for seamless AI integration in radiology.
2025-06
Cortechs.ai
CorTechs Labs announces company rebrand to Cortechs.ai at RSNA 2020
CorTechs Labs rebranded to Cortechs.ai to reflect its evolution in AI imaging software and expanded product lines in oncology imaging, following a merger with HealthLytix.
2020-11

Frequently Asked Questions

CorTechs Labs offers a suite of AI-powered neuroimaging solutions, including NeuroQuant®, NeuroQuant® MS, NeuroQuant® Brain Tumor, NeuroQuant® CT, NeuroQuant® PET, and NeuroQuant® Lesion Surveillance for assessing various neurological conditions like Alzheimer's disease, epilepsy, multiple sclerosis, and traumatic brain injury. For oncology, they provide OnQ™ Prostate for advanced prostate MRI analysis to aid in the detection of clinically significant prostate cancer and NeuroQuant® Brain Tumor for pre- and post-operative 3D volume analysis of brain tumors.
CorTechs Labs is fully compliant with HIPAA regulations, ensuring the secure handling of protected health information. Their processing systems are hosted in highly secure, SSAE 16-compliant/SOC 1, 2, and 3-audited, and ISO 27001 certified facilities in the US and UK. US systems are also HITRUST CSF certified and HIPAA compliant, with all data transfers encrypted using TLS v1.2.
CorTechs Labs operates on a subscription-based business model, licensing its AI technologies to healthcare providers. As of January 1, 2024, new Category III CPT codes (0865T, 0866T) are active for AI-assisted quantitative brain MRI analysis, which apply to CorTechs.ai and other vendor solutions, serving as a step towards permanent reimbursement. Additionally, Category I CPT codes are available for prostate MRI analysis to support reimbursement for prostate cancer detection and evaluation.
CorTechs Labs offers comprehensive support, including a resource library, training videos, and the ability to submit support tickets to their expert service team for a response within 24 hours. They also provide information on Neuro CPT codes and Prostate CPT codes to assist with billing and reimbursement inquiries.
CorTechs Labs has established strategic partnerships with several key players in the healthcare and technology sectors. They have collaborations with Microsoft to integrate AI-driven insights into radiology workflows, Siemens Healthineers to distribute NeuroQuant® Lesion Surveillance, CARPL.ai to expand global access to their imaging solutions, and Viz.ai to integrate NeuroQuant into the Viz.ai platform for neurodegenerative disease assessment.
CorTechs Labs was founded in 2001 and has historically raised $9.1 million in funding. More recently, they successfully closed an oversubscribed Series C funding round led by VILAS Ventures, indicating strong investor confidence in their AI solutions. The company's precision volumetric analysis technology is currently utilized in over 1,400 hospitals and imaging centers worldwide.

Related Companies

A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

NTL Healthcare is a South Korean AI-powered women’s health company specializing in cervical cancer screening and diagnostics. The company has a history dating back to 1996 when it first introduced an analog cervical cancer reading system, Cervicography, to Korea. Since then, NTL Healthcare has evolved its technology, developing the world’s first remote uterine cervical cancer […]

Lumonus is a healthcare technology company that specializes in AI-powered solutions for cancer care, particularly in radiation oncology. The company’s core offering is the Lumonus AI platform, a digital oncology system with AI-native clinical infrastructure designed to automate and orchestrate critical oncology workflows. This platform aims to enhance the quality and speed of care delivery […]

Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.